This April, global leaders in immunization, public health, and biotechnology convened in Washington, D.C. for the 2025 World Vaccine Congress (WVC)—one of the largest and
In collaboration with Instituto de Efectividad Clínica y Sanitaria (IECS) and Tulane University, SPEAC’s Special Populations team has launched a Living Systematic Review focused on the safety, effectiveness,
In collaboration with Instituto de Efectividad Clínica y Sanitaria (IECS) and Tulane University, SPEAC’s Special Populations team has launched a Living Systematic Review focused on the safety, effectiveness,
An Updated Landscape Analysis for the Priority List of Adverse Events of Special Interest (AESI): Chikungunya is now available on Zenodo. A landscape analysis is
We are happy to announce the release of a comprehensive Companion Guide for the Brighton Collaboration Case Definition of Single Organ Cutaneous Vasculitis (SOCV). This new resource
In collaboration with Instituto de Efectividad Clínica y Sanitaria (IECS) and Tulane University, SPEAC’s Special Populations team has launched a Living Systematic Review focused on the safety, effectiveness,
The Safety Platform for Emergency vACcines (SPEAC) is a project funded by the Coalition for Epidemic Preparedness Innovations (CEPI). SPEAC is located at Brighton Collaboration, a program of the Task Force for Global Health.
© SPEAC 2023. All rights reserved.
